Delivery Order SPE2DB20D9127-SPE2DB23FPQJ2
- Not listed
- This federal contract award, valued at $43,220.28, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for 4,559,233,967 units of the oncology medication Oncaspar (pegaspargase) in 5 mL vials. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $43,220.28, is a firm fixed-price delivery order for the supply of 4,556,239,764 units of the oncology drug Oncaspar (pegaspargase) in 5 ml vials. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $43,220.28 firm fixed-price delivery order is for the supply of 4,556,804,056 units of the oncology medication ONCASPAR (pegaspargase) in 5 mL vials. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, which allows the DLA to issue...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $49,531.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 3,750 units of the prescription drug Oncaspar (asparaginase pegylated) in 5 mL vials. This contract is issued under a larger single-award Indefinite Delivery Contract (IDC) valued at $499,999,999, which enables the DLA to place delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $43,220.28 delivery order is for 4,557 units of the oncology medication Oncaspar (Pegaspargase) 3,750 unit/5 mL vial. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,531.40 firm fixed-price delivery order is for the supply of 4,565,482,195 units of the medication ONCASPAR 3,750 UNIT/5 ML VIAL 5ML. The contract is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of Oncaspar (pegaspargase) 3,750 unit/5 mL vials. The order, valued at $86,440.56, is a firm fixed-price contract with no set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $82,930.72 delivery order is for 3,750 units of the oncology medication ONCASPAR in 5 ML vials. The award is under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 between DMS Pharmaceutical Group and the DLA, which enables the DLA to issue delivery orders for a comprehensive...
- This is a delivery order award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $49,531.40 firm-fixed-price contract was issued by the Defense Logistics Agency (DLA) on March 19, 2024 and has an ultimate completion date of April 9, 2024. The award is for 4,564,042,836 units of the oncology drug ONCASPAR (pegaspargase) in 5 mL vials. There is no set-aside designation on this contract. DMS Pharmaceutical Group holds an indefinite delivery contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $86,440.56 firm fixed-price delivery order is for the supply of ONCASPAR 3,750 UNIT/5 ML VIAL 5ML, a pharmaceutical product, to support the medical supply needs of Department of Defense (DoD) healthcare facilities. The award is part of a larger indefinite delivery contract (IDC) valued at up to...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB23FPQJ2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,531.40 firm fixed-price delivery order is for the supply of 4,560 units of the injectable oncology medication Oncaspar (pegaspargase) in 5 mL vials. The delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.5k | 4/13/23 |